Unique Brain ‘Fingerprint’ Can Predict Drug Effectiveness
Personalized medicine, delivering therapies specially tailored to a patient’s unique physiology – has been a goal of researchers and doctors for a long time. New research provides a way of delivering personalized treatments to patients with neurological disease. Researchers at the Montreal Neurological Institute and Hospital (The Neuro) of McGill University and the Ludmer Centre…
New Open Science Partnership Will Pave Way for Better Treatments, Faster
A new partnership between the Structural Genomics Consortium (SGC) and the Montreal Neurological Institute and Hospital (The Neuro) will use a unique open science framework to help scientists discover new targets for drug development for neurological diseases. The partnership, called NeuroSGC, will initially focus on Parkinson’s disease and amyotrophic lateral sclerosis (ALS), two of the…
